(Q36861619)

16 August 2017

1 reference

title

Artesunate-amodiaquine for the treatment of uncomplicated malaria (English)

1 reference

16 August 2017

0 references

0 references

0 references

2

Adama Gansané

1 reference

16 August 2017

1

Sodiomon Bienvenu Sirima

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

Expert Opinion on Investigational Drugs

16 August 2017

published in

1 reference

16 August 2017

volume

16

1 reference

16 August 2017

issue

7

1 reference

16 August 2017

page(s)

1079-1085

1 reference

The burden of malaria mortality among African children in the year 2000.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Antimalarial Drug Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Artemisinin derivatives: toxic for laboratory animals, safe for humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Amodiaquine-induced fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Amodiaquine-induced hepatitis. A report of seven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Systematic review of amodiaquine treatment in uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Averting a malaria disaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Activities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Effects of artemisinin derivatives on malaria transmissibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Why is it that antimalarial drug treatments do not always work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Can amodiaquine be used safely during pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1079

10.1517/13543784.16.7.1079

21 January 2018

Identifiers

DOI

1 reference

release_lwqj6t3mtzaklmgcudmbxrh33a

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lwqj6t3mtzaklmgcudmbxrh33a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference